Cellcept and Skelaxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Skelaxin (metaxalone). Common drug interactions include vomiting among females.

The phase IV clinical study analyzes what interactions people have when they take Cellcept and Skelaxin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Cellcept?

Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.

What is Skelaxin?

Skelaxin has active ingredients of metaxalone. It is often used in back pain. eHealthMe is studying from 9,706 Skelaxin users. Check the latest studies of Skelaxin.



On Jul, 13, 2026

20 people who take Cellcept and Skelaxin together, and have interactions are studied.

Cellcept and Skelaxin drug interactions.

What are the common drug interactions of Cellcept and Skelaxin, by gender? *:

female:

  1. Vomiting
  2. Nausea (feeling of having an urge to vomit)
  3. Weight decreased
  4. White blood cell count decreased
  5. Suicide attempt
  6. Asthma
  7. Cytomegalovirus infection
  8. Drug hypersensitivity
  9. Erythrocyte sedimentation rate increased
  10. Headache (pain in head)

male:

n/a

What are the common drug interactions of Cellcept and Skelaxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Depression
  2. Suicide attempt
  3. Overdose

30-39:

  1. Depression
  2. Dermatomyositis (inflammation of the skin and underlying muscle tissue, typically occurring as an autoimmune condition or associated with internal cancer)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Failure to thrive (inadequate weight gain and physical growth in children)
  5. Hoarseness (changing voice)
  6. Pain
  7. Protein total increased
  8. Pyrexia (fever)
  9. Vomiting
  10. Weight decreased

40-49:

  1. Asthma
  2. Cytomegalovirus infection
  3. Drug hypersensitivity
  4. Hypertension (high blood pressure)
  5. Hypotension (abnormally low blood pressure)
  6. Infection in an immunocompromised host
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Pneumonia
  10. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

n/a

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Vomiting
  3. Oedema (fluid collection in tissue)
  4. Osteomyelitis (infection of bone)
  5. Rigors (an episode of shaking or exaggerated shivering)
  6. Sacroiliitis (an inflammation of the sacroiliac joint)
  7. Spinal column stenosis (narrowing of spinal column)
  8. Spinal cord compression
  9. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
  10. Cardiac valve disease (heart valve disease)

What are the existing conditions these people have? *

  1. Asthma: 4 people, 20.00%
  2. High Blood Pressure: 4 people, 20.00%
  3. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 4 people, 20.00%
  4. Migraine (headache): 3 people, 15.00%
  5. Stress And Anxiety: 3 people, 15.00%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 10.00%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
  8. Herpes Zoster: 2 people, 10.00%
  9. Impaired Gastric Emptying: 2 people, 10.00%
  10. Joint Pain: 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cellcept and Skelaxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cellcept and Skelaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cellcept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Skelaxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cellcept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Skelaxin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil and metaxalone (the active ingredients of Cellcept and Skelaxin, respectively), and Cellcept and Skelaxin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: